NCT04631237
- Conditions
- Abnormalities, Multiple, Chromosome Disorders, Congenital Abnormalities, +8 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Clinical trial condition
Genetic Diseases, Inborn
Explore clinical trials studying Genetic Diseases, Inborn. Study availability and eligibility vary by location and protocol.
12,627 public trials
2,162 recruiting studies
Genetic Diseases, Inborn trial results
NCT04613128
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Cystic Fibrosis in Children, +6 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Stanford University Medical Center Palo Alto, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
NCT06052293
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +6 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Long Beach Memorial Medical Center Long Beach, California, United States
- National Jewish Health Denver, Colorado, United States
- Norton Children's Research Institute affiliated with University of Louisville School of Medicine Louisville, Kentucky, United States
NCT05004363
- Conditions
- ACE Inhibitor Induced Hyperkalaemia, Acute Kidney Injury, Chronic Disease, +22 more
- Locations
-
- St Georges, University of London London, United Kingdom
NCT05864846
- Conditions
- Behavior, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
- Locations
-
- Children's Hospital Colorado Aurora, Colorado, United States
- Yale University School of Medicine New Haven, Connecticut, United States
- University of Florida Health - Department of Neurology Gainesville, Florida, United States
- Nicklaus Children's Health, Miami Miami, Florida, United States
Completed
Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy
NCT05795400
- Conditions
- Amyloid Cardiomyopathy, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +20 more
- Locations
-
- National Medical Research Center for Cardiology, Ministry of Health of Russian Federation Moscow, Russia
NCT03875547
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Søborg, Denmark
- Nagoya University Hospital_Blood Transfusion Aichi, Japan
- Aomori Prefectural Central Hospital_Pediatrics Aomori, Japan
- Matsudo City General Hospital_Pediatrics Chiba, Japan
NCT06191068
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
- Locations
-
- The Hospital for Sick Children Toronto, Ontario, Canada
NCT02700243
- Conditions
- Behavior, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, +7 more
- Locations
-
Not specified
Completed
Tuvusertib (M1774) Human Mass Balance and Absolute Bioavailability Study (DDRIVER Solid Tumors 303)
NCT06308263
- Conditions
- Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
- Locations
-
- Pharmaceutical Research Associates Magyarország Kutatás - Fejlesztési Kft., Klinikai Farmakológiai Vizsgálóhely Budapest, Hungary
Related conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12621)
- Nervous System Diseases (4130)
- Nutritional and Metabolic Diseases (3449)
- Metabolic Diseases (3258)
- Skin and Connective Tissue Diseases (2601)
- Hemic and Lymphatic Diseases (2493)
- Metabolism, Inborn Errors (2480)
- Hematologic Diseases (2279)